Prostatic Hyperplasia
Conditions
Brief summary
The primary objective of this observational study was the assessment of prognosis factors for having recourse to prostatic surgery in patients with BPH who were administered class-1 alpha blockers. The secondary objectives were the assessment of the time from alpha-adrenergic blockade treatment initiation to surgery and the evolution of patients during the study.
Interventions
Sponsors
Boehringer Ingelheim
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
MALE
Healthy volunteers
No
Inclusion criteria
* Any patient with BPH for whom alpha-blocker treatment is indicated * Patients who are already on class-1 alpha-blockers can only participate in the study if all information required is known and/or available
Exclusion criteria
* Patient's follow-up not possible * Patients participating in another study * History of BPH surgery * Prostate cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of prognosis factors for having recourse to prostatic surgery | up to 2 years |
Secondary
| Measure | Time frame |
|---|---|
| Time form alpha-adrenergic blockade treatment initiation to surgery | up to 2 years |
| Occurrence of concomitant BPH diseases | up to 2 years |
| Total International Prostate Symptom Score (IPSS) | up to 2 years |
| Percentage of patients with ongoing BPH treatment | up to 2 years |
Outcome results
None listed